rss feed

Another Academic Medical Leader (This Time at Vanderbilt) Named Corporate Director (This Time at Merck)

Posted on Dec 19, 2007 04:41:00 PM |


We have previously blogged about the apparently major conflicts of interest generated when a leader of an academic medical institution is also simultaneously on the board of directors of one or more for-profit health care corporations.

The Associated Press (here via the Houston Chronicle) just reported that Dr Harry Jacobson has been appointed to the board of directors of Merck and Co. The AP report also noted that Jacobson is on the board of Kinetic Concepts Inc. A cursory Google search revealed Dr Jacobson is a founder of Radiation Oncology Services of America (via the Nashville Business Journal) and was formerly on the board of the Renal Care Group (via PRNewsire).

Meanwhile, Dr Jacobson’s day job is to be Vice-Chancellor of Health Affairs of Vanderbilt University. So here is yet another example of a top leader of an academic health care institution who is also on the board of directors of in this case three for-profit health care corporations, including one of the largest pharmaceutical companies in the world, plus two smaller local companies.

According to the Third Edition of Corporate Governance by RAG Monks and N Minow, a member of the board of directors of a public, for-profit company must “demonstrate unyielding loyalty to the company’s stockholders.” So it would appear that Dr Jacobson, like other top leaders of academic medical institutions who serve on the boards of for-profit health care corporations, has quite some conflicts of interest. How can he simultaneously demonstrate “unyielding loyalty” to a pharmaceutical company, a company that produces wound care therapeutics products, and a company that provides outpatient radiology services, and meanwhile be devoted to the health care mission of Vanderbilt University? But at the moment, nobody at the University seems concerned about it. And these kinds of conflict of interest have excited little interest, while many bytes and much ink and paper address the conflicts generated when medical students, interns and residents, or practicing doctors receive pens or mugs with corporate logos, or free pizzas (see this post). Go figure, and let the good times roll….

[Source : Health Care Renewal]

Please take the time to visit original contents source to find out more about topic you are interested.

Sponsored Links :

  • 1TBM: Vaccines and Medical Experiments on Children, Minorities ...


    Merck Pharmaceuticals President George Merck is named director of the War Research Service (WRS), an agency designed to oversee the establishment of a biological warfare program (Goliszek). ..... Bloomberg releases a series of reports suggesting that SFBC, the largest experimental drug testing center of its time, exploits immigrant and other low-income test subjects and runs tests with limited credibility due to violations of both the FDA's and SFBC's own testing ...more
  • FLU VACCINES: ARE THEY EFFECTIVE AND SAFE?


    I think it's the height of arrogance for the medical profession to think that they have duplicated a biological process that has taken care of people since the beginning of time. People can deal with infectious diseases without vaccines ...more
  • FDA Approves Multaq(R) for Patients With Atrial Fibrillation or ...


    The ATHENA trial, which involved 4628 patients with AF or AFL and more than 2300 patients receiving Multaq(R) on top of standard therapy, demonstrated a 24% reduction in time to first CV hospitalization or all-cause mortality (P<0.001) compared ..... July 9th, 2009 Merck, Portola in $420M deal for anticlotting drugWHITEHOUSE STATION, N.J. — Merck & Co. Drug to prevent exercise-induced arrhythmias identified. March 30th, 2009 LONDON - Vanderbilt University Medical Center ...more
  • Q&A: Head of J&J's COSAT on 'Renting to Own' and Other Tech ...


    For a long time we've prided ourselves at being one of the premier partnering companies in the biomedical industry, including partnerships with academic institutions, small companies, and large companies, as well as public-private consortia . ... Three leaders from the Human Genome Project — David Botstein, Francis Collins, and Eric Lander — have been named co-winners of the 2010 Albany Medical Center Prize in Medicine and Biomedical Research, which carries with it a purse ...more
 
 

Leave a comment:

hostgator